ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin.

Lin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.